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Abstract
The objects of study is concerted to investigate the occurrence of Ureaplasma parvum in 
women with recurrent abortion and to determine the distribution of U. parvum serovars 
(1, 3, 6, 14) in women with recurrent abortion by conventional polymerase chain reaction 
(PCR) technique. In total, 130 samples included vaginal bleeding, vaginal swab, and urine, 
were collected from women with recurrent abortion and 40 samples included vaginal swab 
and urine from control women without recurrent abortion. Through the study, two types of 
media were used, Ureaplasma broth (IH Broth) and Ureaplasma agar (IH Agar). The positive 
isolates for Ureaplasma spp. were investigated by conventional PCR technique for identifi-
cation of U. parvum and subtyping to their serovars (1, 3, 6, 14). The results revealed the U. 
parvum was identified in 29.6% from patient group and 11% from the control group. U. par-
vum isolates were further subtyped by using PCR, the results showed the serovar 3 was the 
most frequent isolate in proportion (42.8%), whereas serovar 1 (28.5%), serovar 6 (14.2%), 
and serovar 14 (14.2%) in patient group but in the control group only serovar 1 was isolated 
in rate (11%). These results evidently indicate that U. parvum may be an important etiologic 
agent for recurrent abortion.
Keywords: IH medium, PCR, recurrent miscarriage, serovars, Ureaplasma parvum
1. Introduction
Recurrent miscarriage is the loss of three or more consecutive pregnancies ending of preg-
nancy by removing a fetus or embryo before it can survive outside the uterus [1, 2]. A mis-
carriage which occurs spontaneously is also known as a miscarriage and World Health 
Organization (WHO) explained the around 56 million recurrent miscarriage before the 24th 
week of gestation occur each year in the world unexplained [3].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Any sever infection that leads to bacteraemia or viraemia can cause sporadic miscarriage. The 
role of infection in recurrent miscarriage is unclear; the presence of bacterial vaginosis in the 
first trimester of pregnancy has been reported as a risk factor for second-trimester miscarriage 
and preterm delivery [4].
Ureaplasma parvum could be important pathogen that may affect pregnancy outcomes and the 
health of neonates was first given serious consideration when reported of postpartum endo-
metritis with septicemia, chorioamnionitis [5]. Since those days, numerous clinical studies 
have been performed in an attempt to clarify what roles, if any, these organisms play as agents 
responsible for invasive infections in neonates, premature labor, spontaneous miscarriage, 
stillbirth, and chronic lung disease of prematurity [6].
Although more than 30 years of study inside and outside of Iraq, many clinical importance 
of genital Ureaplasma parvum are still incompletely understood for a variety of reasons. These 
include (1) the high prevalence of these organisms in healthy persons; (2) poor design of many 
of the earlier research studies, which attempted to relate the more presence of Ureaplasma parvum 
in the lower urogenital tract to pathology in the upper tract or in offspring; (3) unfamiliarity 
of clinicians and microbiologists with the complex and fastidious nutritional requirements for 
Ureaplasma parvum and the methods detection [7].
Ureaplasma parvum found in the placenta and endometrium is associated with infection, the 
birth of a dead fetus, spontaneous miscarriage, premature delivery and lowers than normal 
weight of infant. Ureaplasma parvum penetrate into amnion in the second trimester it may 
cause chorioamnionitis [3]. Ureaplasma parvum was found in the blood of mothers who have 
had problems with high fever after childbirth this infection can be transmitted to about 40% of 
babies who were born to a mother with this infection if the mother has it, Ureaplasma parvum 
can infect the lungs of the newborn during childbirth [8].
Ureaplasma parvum are the most prevalent, possibly pathogenic bacteria isolated from the uro-
genital tract of both men and women, they are also frequently associated with preterm birth 
and other adverse pregnancy outcomes [9]. Genital U. parvum (biovar 2, serotypes 1, 3, 6 and 
14) are considered natural inhabitants of the lower urogenital tract of humans as they are 
often isolated from healthy individuals and involved in a variety of infections in humans the 
isolation of U. parvum from patients with genitourinary tract infections [10]. Waites [5] found 
U. parvum to be dominant in patients with pelvic inflammatory disease as well as in women 
who had miscarriages, and it seemed to have more adverse effects on pregnancy outcome 
regarding birth weight, gestational age, and preterm delivery than U. urealyticum and shown 
that U. parvum can be isolated more frequently from patients with a history of recurrent mis-
carriages than from normal pregnant women.
Ureaplasma parvum are the microorganisms most frequently isolated from amniotic fluid 
(AF) or placentae in women who deliver preterm between 23 and 32 weeks pregnancy and 
U. parvum has been linked with adverse pregnancy outcomes such as late miscarriage and 
early preterm birth Also identified U. parvum in 57% of healthy non pregnant women and the 
organism was far more prevalent than any of the other genital mycoplasma, Chlamydia spp. 
or viruses [11]. Ureaplasma parvum infections require the therapeutic use of antimicrobials. 
Tetracyclines, macrolides and quinolones are the major antibiotics used in the treatment of 
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genital Ureaplasma. However, their therapeutic efficacy may be unpredictable due to increas-
ing resistance [9]. Ureaplasma spp. is the most prevalent, possibly pathogenic bacteria isolated 
from the urogenital tract of both men and women [9]. Ureaplasma spp. are also frequently 
associated with preterm birth and other adverse pregnancy outcomes and Ureaplasma spp. 
are colonies isolated in female genitourinary tract sometimes these microorganisms do not 
evaluate as infectious agents [12]. Detection of Ureaplasma is possible by the characteristic 
growth on appropriate media and urease activity, but species identification of U. urealyticum 
and U. parvum must be demonstrated by molecular methods [10]. Differentiation between 
U. parvum and U. urealyticum is very important, especially for correct interpretation of labo-
ratory results and evaluation of pathogenicity [13]. Ureaplasma spp. do not have cell wall, 
are fastidious and mostly referred to as no cultivable organisms [12]. Genital tract infec-
tions with Ureaplasma caused approximately 50% of preterm labor and recurrent abortion 
[9]. Most of Ureaplasma infected pregnancies produced infant with low weight at birth with 
increased risk of recurrent abortion (at or before 14 weeks). Also, 60% of mortality among 
infants with no anatomic or chromosomal defects is low birth weight [14]. U. parvum has 
been linked with adverse pregnancy outcomes such as late abortion and early preterm birth. 
Ureaplasma spp. are the microorganisms most frequently isolated from amniotic fluid or pla-
centae in women who deliver preterm between 23 and 32-weeks pregnant [13, 15]. U. parvum 
are involved in a variety of infections in genitourinary tract infections of humans [10, 16]. 
Identified U. parvum in 57% of healthy non pregnant women and the organism was far more 
prevalent than any of the other genital mycoplasmas, Chlamydia spp., or viruses [11, 17]. The 
proposed mechanisms for infectious causes of recurrent abortion include: direct infection of 
the uterus, fetus, or placenta; placental insufficiency; chronic endometritis or endocervicitis; 
amnionitis; infected intrauterine device [18, 19]. Ureaplasma can be detected in the cervix 
or vagina of 40–80% of sexually mature asymptomatic women [20]. U. parvum may play 
important role in pregnancy and eliciting conditions associated with prematurity [21]. The 
main aim of this study is to investigate the occurrence of U. parvum in women with recurrent 
abortion and to determine the distribution of U. parvum serovars (1, 3, 6, 14) in women with 
recurrent abortion by conventional polymerase chain reaction (PCR) technique.
2. Materials and methods
2.1. The bacterial isolates
In total, 130 samples included vaginal bleeding, vaginal swab, and urine, were collected from 
women with recurrent abortion and 40 samples included vaginal swab and urine from control 
women without recurrent abortion. All specimens were cultured in IH broth, which consists of 
PPLO broth, tryptone soya broth, yeast extract powder, distilled water, and supplements [22]. 
Then make a subculture to IH agar, which consists of PPLO agar, tryptone soya broth, MgSO
4
·H2O, 
yeast extract powder, agar-agar, distilled water, and supplements [22]. The Ureaplasma spp. iso-
lates were identified by examination of colonial morphology on IH agar media as dark golden-
brown or rich, deep brown, and granular appearance because of accumulation of magnesium 
oxide inside and outside the colony [17].
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Organism Primer (F)/(R) Sequence (5′-3′) Size of amplified 
product (bp)
Target gene
U. parvum
Serovar 1
UMS-83/UMA1A F (TTACT GTA GAA ATT ATG  
TAA GAT TGC)
R (TTT CTT TTG GTT CTT  
CAG TTT TTG AAG)
578 MBA
U. parvum
Serovar 3
UMS3S/UMA269 F (TTA CTG TAG AAA TTA TGT 
AAG ATT ACC)
R (AA CTA AAT GAC CTT TTT 
CAA GTG TAC)
400 MBA
U. parvum
Serovar 6
UMS-54/UMA269 F (AAT CTT AGT GTT CAT ATT 
TTT TAC TAG)
R (ACCA AAT GAC CTT TTG  
TAA CTA GAT)
370 MBA
U. parvum
Serovar 14
UMS14S/UMA314A F (AAT TAC TGT AGA AAT TAT 
GTA AGA TTA AT)
R (GTT GTT CTT TAC CTG GTT 
GTG TAG)
572 MBA
MBA, multiple band antigen; U. parvum, Ureaplasma parvum. Adapted with permission from [23–25].
Table 2. PCR primers employed for subtyping of Ureaplasma parvum in to serovars.
2.2. Molecular experiments
Molecular experiments included the extraction of Ureaplasma DNA by using the Reagent 
Genomic DNA Kit (Geneaid, New Taipei, Taiwan). PCR identification of U. parvum was done 
according to Kong et al. [23, 24] and master mix kit (BioNeer, Irvine, California). PCR was 
performed with primers specific for highly conserved regions in the 50 end of multiple band 
antigen gene of U. parvum. Primer for diagnosis of U. parvum, UMS-57/UMA222, is shown in 
Table 1 [23, 24]. The primers for detection of serovars UMS3S/UMA26, UMS14S/UMA314A, 
UMS-83/UMA1A, and UMS-54/UMA269 (BioNeer, Irvine, California) are shown in Table 2 
[23, 24] and were used for subtyping of U. parvum to amplify the repetitive of the multiple 
band antigen genes of U. parvum serovars.
Organism Primer (F)/(R) Sequence (5′-3′) Size of amplified 
product (bp)
Target gene
U. parvum UMS-57 F (TAA ATC TTA GTG TTC  
ATA TTT TTT AC -57)
326 5′ Ends of MBA genes and 
upstream regions
UMA222 R (GTA AGTGGA TTA AAT 
TCA ATG 222)
MBA, multiple band antigen. Adapted with permission from [23–25].
Table 1. PCR primer employed in the detection of Ureaplasma parvum.
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2.3. PCR technique
The 20 ul amplification reaction mixtures contained 10 pmol of each primer, 5 ul of DNA 
template, and PCR water added to 20 ul for identification U. parvum. The PCR conditions were 
used as follows: initial denaturation at 95°C for 5 min, denaturation at 95°C for 30 s, annealing 
at 58°C for 30 s, extension at 72°C for 1 min for 40 cycles, and final extension at 72°C for 5 min 
in a thermo cycler. The PCR positive isolates for U. parvum were further subtyped into serovars 
as described in Table 2. Briefly, the PCR conditions were used as follows: initial denaturation 
at 95°C for 5 min, denaturation at 95°C for 30 s, annealing at 55–62°C for 30 s, extension at 72°C 
for 1 min for 40 cycles. Amplified PCR products (12.5 ul) were visualized under UV light after 
electrophoresis in 2% agarose gel which was stained with 0.5 mg/ml of ethidium bromide. A 
visible band of the appropriate size on UV transillumination was considered a positive result.
3. Statistical analysis
The data were analyzed using SPSS statistic software version 20 (IBM, Armonk, USA) for com-
parison of qualitative variables using P < 0.05 and odd ratio. Association between U. parvum 
infection and recurrent abortion was statistically significant.
4. Results and discussion
4.1. Laboratory identification of Ureaplasma spp. (colonial morphology)
In this study Ureaplasma spp. isolates was identified by examination of colonial morphology on 
IH agar media used in this study as dark golden-brown or rich deep brown and granular appear-
ance. All isolates revealed positive urea analysis. These results were in accordance with [17, 26].
4.2. Isolation of Ureaplasma spp. on culture media
Detection of Ureaplasma spp. is possible by characteristic growth on appropriate culture media 
but species identification of U. parvum along with serovar identification by molecular method 
is important especially for correct interpretation of laboratory results and evaluation of patho-
genicity. In present study, Ureaplasma broth media (IH broth) & Ureaplasma agar media (IH 
agar) were used to isolate Ureaplasma spp. the rate of isolate are (52.3%) from vaginal bleed-
ing, (30.7%) from vaginal swab and (7.6%) from urine. The reason for the high isolation of 
Ureaplasma spp. on IH medium can be attributed to supplementation with DNA, Putrescine 
– dihydrochloride, cysteine which enhances the microorganisms with lipid materials essential 
for growing of these bacteria. Also a mixture of antibiotics was used (Ceftriaxone, Amoxicillin, 
Augmentin, Nystatine, & Fluconazole) to prevent contamination may occur in the conven-
tional broth media. The amount of horse serum reduced from 20 to 10 ml to reduce the cost 
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and it is sufficient for growth of these microorganisms. Ureaplasma agar media (IH medium) 
is supplemented with essential requirements for growing of these microorganisms. These 
are horse serum, yeast extract, urea, cysteine, antibacterial and antifungal that inhibited the 
growth of other bacteria and fungi and the optimal PH (6.0) [22].
The medium contains urea and sensitive indicators of ammonia, Manganous sulfate which is 
firstly used by [27]. Sulfate salt of manganese was described to support the growth. Manganous 
sulfate was added in a final concentration of 0.03% was therefore, selected as the ammonia – 
detecting reagent of choice. Ureaplasma spp. colonies appeared within 2 days, identified as dark 
golden-brown owing to accumulation of manganese oxide in the colony.
Moreover, putrescine – dihydrochloride was added to enhance the Ureaplasma spp. growth 
and development of the precipitate in the colonies (Phillips et al., 1986). In addition the size of 
Ureaplasma spp. were seen to be larger when add putrescine – dihydrochloride. The original-
ity of this media can be attributed to horse serum (10%) instead of (20%), yeast extract as a 
powder, BBL tryptone soya broth together with PPLO, also used DNA and putrescine in same 
medium. Moreover the mixture of antibiotics prevents contamination of medium by bacteria 
and fungi that easily contaminate conventional media. Moreover, agar – agar was added to the 
medium was more than 3% which believed it inhibited the bacterial growth [22]. Therefore, 
IH media considered as enrichment, differential and selective for Ureaplasma spp. because it 
resolved the important problem of culturing these bacteria.
Other study used IH medium for isolate Mycoplasma spp. and Ureaplasma spp. [28] isolated 
Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum on IH medium from infer-
tile male in rate (5.8%), (5.8%) and (3.5%) respectively. Also [29] isolated Mycoplasma pneumoniae 
in rate (18%) on IH media from tonsillitis patients. Another study was isolated Ureaplasma urea-
lyticum in rate (16.8%) from infertile female, (20%) from infertile male and isolated Mycoplasma 
hominis in rate (27.7%), (1.6%) from infertile female and male respectively on MAU-medium 
similar to IH medium [30]. In the present study the results on IH medium Ureaplasma spp. was 
identified as dark golden-brown or rich deep brown colonies Figure 1. Moreover, Ureaplasma 
spp. was identified by its granular appearance Figure 2.
Figure 1. Ureaplasma spp. as dark golden-brown colonies in IH medium under light microscope 10X.
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4.3. Comparison between age groups of miscarried women and percentage of 
isolation of Ureaplasma spp.
The results of this study showed that the age patients range 17–26 & 27–36 years old represented 
a high rate (46%), (40.7%) respectively compared with group (37–46) represented (13.3%) as 
shown in Figure 3 included in this study. The incidence of Ureaplasma spp. infection was also 
reported by some other studies as higher in age 26–30 years [31]. The high isolation detection 
in miscarried women of age group 17–26 & 27–36 years. This may be attributed to the sexual 
activity of females together with hormonal change, so the genital tract is more susceptible for 
infection [32]. The high rate of Ureaplasma spp. infection detected in this study suggests that this 
agent is widespread among miscarried women.
Figure 2. Ureaplasma spp. as granular appearance in IH medium under light microscope 10X.
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Figure 3. Histogram showing the distribution of Ureaplasma spp. according to 10 years age intervals of patients with 
recurrent miscarriage.
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This can be attributed to the sexual activity among this groups since there is an increased in 
estrogen hormone produced from female genital tract leading to change the vaginal environ-
ment which is regarded as a factor for infection [33]. because the estrogen is important hor-
mone during pregnancy, it makes to adjust the level of the hormone progesterone is essential 
in the formation and development of the fetus, so pregnancy is one of the reason leading 
to the rise in the hormone estrogen [34]. For this reason, when the increased of estrogen, it 
affects the hormone progesterone is necessary in pregnancy, which affects the thickness of 
the lining of the uterus and the difficulty of adapt fetus with her. However it is generally dif-
ficult to determine whether these agents cause colonization or infection. Since the incidence of 
infection is affected by some factors, such as: menstrual cycle, bacterial and protozoan infec-
tion (co-infections), and socio-economic conditions like poverty. Also the age group 17–26 & 
27–36 years are the most widely accepted for marriage and reproduction in our society for this 
reason the proportion of isolation the Ureaplasma spp. be high. It has been shown in this study 
that the percent of isolation of Ureaplasma spp. was directly associated with age. The isolation 
rate decrease in 37–46 years this may be due to the changes that associated with a decrease 
in the incidence of genital Ureaplasma, also due to vagina multilayer lining are atrophic in 
ages 37–46 years old. All of these reasons associated with decrease in the incidence of genital 
Ureaplasma spp. From the results of this study, can conclude that the genital Ureaplasma were 
significant correlation with age. Statistical analysis: (P-value = 0.001) appeared highly signifi-
cant between patients and controls according to age interval with (P < 0.05).
4.4. Relationship between the isolation of genital Ureaplasma spp. and type of 
specimen
Figure 4 shows the distribution of bacterial isolate of genital Ureaplasma according to the clinical 
specimen. The results exhibited that vaginal bleeding from miscarried women given high per-
centage of isolation (52.3%) followed by vaginal swab (30.7%) and urine (7.6%). According to the 
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Figure 4. Distribution of genital Ureaplasma spp. isolate among clinical specimen.
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available knowledge genital Ureaplasma spp. are not screened by routine examination of vaginal 
bleeding, urine, vaginal swab from miscarried woman in health laboratories in Iraq. Little studies 
that working culture examine for detection of these organisms in specimens taken from miscar-
ried woman. The results obtained by this study explain isolated genital Ureaplasma in percentage 
more than 38% from vaginal bleeding samples, this may be due to dysfunction of placenta and 
the vaginal bleeding is a marker for placental dysfunction, vaginal bleeding is most likely to be 
seen around the time of the luteal-placental shift [35]. There has been little investigation of first 
trimester bleeding. It is interesting that the peak in bleeding episodes coincides with the develop-
ment of a hormonally functional placenta. In very early pregnancy, the corpus luteum produces 
progesterone. The shift from luteal production to placental production of progesterone occurs by 
the seventh week of pregnancy and can result in a temporary reduction in progesterone levels if 
the placenta is not producing sufficiently [36]. Decreasing levels of progesterone are associated 
with the onset of menses outside of pregnancy; similarly, during pregnancy, decreasing levels 
may trigger an episode of vaginal bleeding and limit successful maintenance of the pregnancy. 
Thus, bleeding at this time in pregnancy may signal that the early placenta has not developed 
optimally [37]. One of the routes of intrauterine infection with Ureaplasma spp. by hematogenous 
dissemination through the placenta this mechanism occur by which microorganisms are able to 
pass through the cervix, infect the maternal and fetal (chorioamnion) layers of the placenta and 
often access the amniotic fluid and outcome common intramniotic infection lead to abortion [19].
An explanation for these variations may be related to the type of specimens investigated for 
isolation, the methods used for transport and storage, and media used for primary isolation 
of Ureaplasma spp. In light of the observation and experience during this study, centrifuged 
urine sediments yield more positive cultures than the urine specimen without centrifuged.
4.5. Molecular detection for diagnostic of Ureaplasma parvum by polymerase chain 
reaction (PCR)
The results showed the Ureaplasma parvum isolated in rate (29.6%) from women with recur-
rent abortion and (11%) from control as shown in Figure 5 (P-value <0.05 appeared highly 
significant). The results revealed positive isolates for Ureaplasma parvum by using UMS-57/
UMA222 primer as shown in Figure 6. The negative isolates for U. parvum may be because of 
the fact that Ureaplasma are divided into two species U. parvum and U. urealyticum, these two 
species cannot be identified by characteristic growth on appropriate media and only identi-
fied by molecular methods [23, 25]. So the negative results may be Ureaplasma urealyticum 
rather than Ureaplasma parvum and the results appeared to be attributable to a higher pro-
portion of women with recurrent abortion. It may be hormonal effects which could increase 
Ureaplasma parvum counts and thus the likelihood of detection during pregnancy. A previous 
study showed that there is Ureaplasma parvum in rate (20%) from women with recurrent abor-
tion in China by using PCR technique [38].
Although Ureaplasma parvum was isolated in rate (25%) from women with symptoms of ure-
thral, cervical discharge, genital pruritis, dysuria in India [24, 39]. However, some other studies 
detected this organism in high rate (approximately 79%) from pregnant women and women 
with sexually transmitted disease in Australia [23]. Ureaplasma parvum positive isolates were 
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further subtyped into serovars 1, 3, 6, 14; the results revealed Ureaplasma parvum (biovar 2) 
serovar 3 was predominant among woman with recurrent abortion. As shown in Figures 7–9, 
Ureaplasma parvum serovar 3 was isolated in proportion 42.8%, the most frequent isolate in 
women with recurrent abortion followed by serovar 1 in proportion 28.5%, whereas serovar 
6 and 14 showed the same proportion (14.2%) detected it in patient group; however, in con-
trol group, only Ureaplasma parvum serovar 1 was isolated in proportion of 11%. Among the 
different serovars of Ureaplasma parvum, serovar 3 was the most frequent serovar detected in 
the patient group. Therefore, Ureaplasma parvum (biovar 2) serovar 3 was predominant among 
woman with recurrent abortion. We suggested the Ureaplasma parvum serovar 3 may be play-
ing a role in recurrent abortion and prematurity. Also may be related to intra- amniotic inflam-
matory response to Ureaplasma parvum and that this is related not only to recurrent abortion 
but also to early onset sepsis in the baby. Although the difference in detection rates of the dif-
ferent serovars of Ureaplasma parvum was statistically significant, the predominance of serovar 
3 was consistent with previous reports [24]. Another study detected Ureaplasma parvum serovar 
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Figure 5. Prevalence of Ureaplasma parvum among patient group and control group.
Figure 6. Ethidium bromide-stained agarose gel showing PCR amplification product with (326 bp) primers for 
Ureaplasma parvum. M 100 bp standard size reference marker. Lanes (1, 3, 5, 6, 7, 9, and 11): Ureaplasma parvum positive 
results. Lanes (2, 4, 8, 10, and 12): Ureaplasma parvum negative samples.
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3 is the most prevalent serovar detected in reproductive humans [40]. Another study isolated 
the complete genome sequence of Ureaplasma parvum serovar 3, clinical strain SV3F4, isolated 
from a Japanese patient who had an infectious abortion during the 13th gestational week in her 
previous pregnancy [41, 42]. Also Urszula et al. [10] isolated Ureaplasma parvum serovar 3/14 in 
86% of women with symptomatic genital tract infections. It is possible that the combination 
of variable serovar-specific genes of Ureaplasma with generally known virulence factors deter-
mines the development of pathological processes on the mucosal surface of the human genital 
tract and respiratory tract in infant [43, 44].
Figure 7. Distribution of Ureaplasma parvum serovars among patient group and control group.
Figure 8. Results of PCR amplification for identification of serovar 1 (578 bp) and serovar 3 (400 bp). M 100 bp standard 
size reference marker. Lane (1, 5): serovar 1 positive results. Lane (2, 3, 4, 6, 7, 8, 9): negative samples. Lane (10, 14): 
serovar 3 positive results. Lane (11, 12, 13, 15, 16, 17): negative samples.
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5. Conclusion
The results evidently indicate that U. parvum may be an important etiologic agent for recurrent 
abortion. And U. parvum serovar 3 was the most frequent serovar isolated in this study. It may 
play a role in recurrent abortion.
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